10521 related articles for article (PubMed ID: 10666478)
1. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.
Yang P; Farkas DL; Kirkwood JM; Abernethy JL; Edington HD; Becker D
Mol Med; 1999 Dec; 5(12):785-94. PubMed ID: 10666478
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.
Yang P; Becker D
Int J Oncol; 2000 Nov; 17(5):913-9. PubMed ID: 11029492
[TBL] [Abstract][Full Text] [Related]
3. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas.
Smith AP; Hoek K; Becker D
Cancer Biol Ther; 2005 Sep; 4(9):1018-29. PubMed ID: 16251803
[TBL] [Abstract][Full Text] [Related]
5. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
Dong J; Phelps RG; Qiao R; Yao S; Benard O; Ronai Z; Aaronson SA
Cancer Res; 2003 Jul; 63(14):3883-5. PubMed ID: 12873977
[TBL] [Abstract][Full Text] [Related]
6. Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.
Kirkwood JM; Farkas DL; Chakraborty A; Dyer KF; Tweardy DJ; Abernethy JL; Edington HD; Donnelly SS; Becker D
Mol Med; 1999 Jan; 5(1):11-20. PubMed ID: 10072444
[TBL] [Abstract][Full Text] [Related]
7. Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasize.
Abramova L; Slingluff CL; Patterson JW
J Cutan Pathol; 2002 Aug; 29(7):407-14. PubMed ID: 12139635
[TBL] [Abstract][Full Text] [Related]
8. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
[TBL] [Abstract][Full Text] [Related]
9. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.
Elder DE; Clark WH; Elenitsas R; Guerry D; Halpern AC
Semin Diagn Pathol; 1993 Feb; 10(1):18-35. PubMed ID: 8506414
[TBL] [Abstract][Full Text] [Related]
10. Expression of thyrotropin-releasing hormone by human melanoma and nevi.
Ellerhorst JA; Naderi AA; Johnson MK; Pelletier P; Prieto VG; Diwan AH; Johnson MM; Gunn DC; Yekell S; Grimm EA
Clin Cancer Res; 2004 Aug; 10(16):5531-6. PubMed ID: 15328193
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
[TBL] [Abstract][Full Text] [Related]
12. Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization.
Wiltshire RN; Duray P; Bittner ML; Visakorpi T; Meltzer PS; Tuthill RJ; Liotta LA; Trent JM
Cancer Res; 1995 Sep; 55(18):3954-7. PubMed ID: 7664261
[TBL] [Abstract][Full Text] [Related]
13. Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets.
Sousa JF; Espreafico EM
BMC Cancer; 2008 Jan; 8():19. PubMed ID: 18211678
[TBL] [Abstract][Full Text] [Related]
14. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
Barnhill RL
Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
[TBL] [Abstract][Full Text] [Related]
15. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
Hussein MR; Elsers DA; Fadel SA; Omar AE
J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
[TBL] [Abstract][Full Text] [Related]
16. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
19. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
20. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.
Sturm RA; Satyamoorthy K; Meier F; Gardiner BB; Smit DJ; Vaidya B; Herlyn M
Cancer Res; 2002 Jan; 62(1):226-32. PubMed ID: 11782382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]